US2017065553A1PendingUtilityA1

Orally dispersible tablet

Assignee: TAKEDA PHARMACEUTICALS COPriority: Jan 17, 2011Filed: Nov 18, 2016Published: Mar 9, 2017
Est. expiryJan 17, 2031(~4.5 yrs left)· nominal 20-yr term from priority
A61P 25/24A61P 25/18A61P 25/00A61K 9/2013A61K 31/343A61K 9/2059A61K 9/2095A61K 9/2027C07D 307/81A61K 9/2018A61K 9/205A61K 9/2031A61K 9/006A61K 9/2054A61K 9/2081A61K 9/0056A61K 9/2063A61K 9/16A61K 9/14A61K 9/20
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides a preparation with improved disintegration property, a preparation showing improved bioavailability of a medicament, production methods thereof and the like. A rapidly disintegrating preparation comprising granules comprising a medicament coated with a coating layer containing sugar or sugar alcohol; and a disintegrant. A production method of a rapidly disintegrating preparation including a step of producing granules comprising a medicament, a step of forming a coating layer containing sugar or sugar alcohol on the obtained granules and a step of mixing the coated granules with a disintegrant and molding the mixture.

Claims

exact text as granted — not AI-modified
1 . A rapidly disintegrating preparation comprising granules comprising a medicament coated with a coating layer containing sugar or sugar alcohol; and a disintegrant. 
     
     
         2 . The rapidly disintegrating preparation according to  claim 1 , wherein the granules comprising a medicament further contains a binder. 
     
     
         3 . The rapidly disintegrating preparation according to  claim 1 , wherein the granules comprising a medicament further contains a masking agent. 
     
     
         4 . The rapidly disintegrating preparation according to  claim 1 , wherein the granules comprising a medicament further contains a solubilizer. 
     
     
         5 . The preparation according to  claim 1 , which is for oral-mucosal absorption. 
     
     
         6 . The preparation according to  claim 5 , wherein the medicament is (S)—N-[2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl]propionamide. 
     
     
         7 . The preparation according to  claim 5 , which is a tablet. 
     
     
         8 . A method of producing a rapidly disintegrating preparation, comprising a step of producing granules comprising a medicament,
 a step of forming a coating layer containing sugar or sugar alcohol on the obtained granules, and   a step of mixing the coated granules with a disintegrant and molding the mixture.   
     
     
         9 .- 33 . (canceled)

Join the waitlist — get patent alerts

Track US2017065553A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.